Quantcast
Last updated on April 21, 2014 at 8:55 EDT

Latest Chronic fatigue syndrome Stories

2008-12-10 13:46:47

Sixteen percent of Georgia's residents have trouble staying awake during the day, U.S. heath officials said. A study by the Centers for Disease Control and Prevention in Atlanta and published online in the American Journal of Epidemiology points to the importance of diagnosing and treating sleep problems before they could potentially develop into long-term health issues. The study also found that in addition to problems staying awake: -- 35 percent of Georgians wake up feeling unrefreshed....

2008-12-03 14:00:00

CHARLOTTE, N.C., Dec. 3 /PRNewswire/ -- The four million Americans who suffer from chronic fatigue syndrome (CFS) have new reason for hope today with the announcement of an unprecedented research program to help identify biomarkers for the illness and improve diagnosis and treatment of CFS. The announcement was made by the CFIDS Association of America, which is funding the program, called the Accelerate CFS Research Initiative. As part of this initiative, the CFIDS Association also...

2008-10-21 09:00:54

PHILADELPHIA, Oct. 21, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its Medical Director, Dr. David Strayer, will present clinical data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C. on October 27, 2008. ICAAC is one of the largest medical/scientific conferences held annually in U.S. The presentation, entitled "Review of the Integrative Studies Supporting an NDA for Ampligen(r) in the...

2008-09-13 12:00:08

By Lois M. Collins Deseret News Understanding of fibromyalgia -- and even its recognition as a legitimate illness -- has come a long way in the past few years. But the most important advance is Food and Drug Administration approval of two drugs to modulate the nerve pain or central nervous pain that marks the illness. That's according to Dr. Lucinda Bateman, a Salt Lake City doctor who was treating the condition long before many of her colleagues had stopped debating whether it's real....

2008-09-12 09:00:09

By Lois M. Collins Deseret News Understanding of fibromyalgia --and even its recognition as a legitimate illness -- has come a long way in the past few years. But the most important advance is Food and Drug Administration approval of two drugs to modulate the nerve pain or central nervous pain that marks the illness. That's according to Dr. Lucinda Bateman, a Salt Lake City doctor who was treating the condition long before many of her colleagues had stopped debating whether it's real....

2008-08-12 00:00:11

By Roger Dobson Doctors call them heart-sink cases: the one in four patients whose symptoms have no known cause. So are they really ill? Roger Dobson investigates Most patients expect a quick diagnosis and cure from their doctor. But what if nothing can be found? What if there is no medical explanation for the symptoms, let alone a cure? More than one in four patients visiting their GP have unexplained pain or symptoms, according to a new report. Other research suggests that up to 50 per...

2008-07-26 18:00:17

By Shawn Burnette, Daily Press, Newport News, Va. Jul. 26--Judy McClary, leader and founder of the Tidewater Chronic Pain & Chronic Illness Support Group in Chesapeake, holds monthly meetings at her house for those suffering from chronic pain or chronic illnesses. It is a place where people can come together and give each other support and encouragement. McClary, a registered nurse and certified legal nurse consultant, works with and has chronic fatigue syndrome. She's trying to raise...

2008-07-09 09:00:13

Hemispherx Biopharma has reported that the FDA has accepted for review the company's new drug application for Ampligen, an experimental therapeutic, to treat chronic fatigue syndrome, originally submitted in October 2007. Hemispherx is seeking marketing approval for the first-ever treatment for chronic fatigue syndrome (CFS). At present, only supportive, symptom-based care is available for CFS patients. The new drug application (NDA) for Ampligen is also said to be the first ever...

2008-07-08 09:00:00

PHILADELPHIA, July 8, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug Application (NDA) for Ampligen(r), an experimental therapeutic, to treat Chronic Fatigue Syndrome (CFS), originally submitted in October 2007. Hemispherx is seeking marketing approval for the first-ever treatment for CFS. At present, only supportive, symptom-based care is available for CFS patients....

2008-06-27 06:02:13

By Hunter, Suzanne JOURNALS WATCH Too busy to catch up on the latest research? Let Dr Suzanne Hunter update you on recent papers Genetic screening for osteoporosis Lancet 2008; 371:1,505-12 Osteoporosis causes significant morbidity and mortality. It has long been recognised that there is a strong hereditary basis for osteoporosis. The aim of this study was to identify genetic loci that are associated with bone mineral density. The international team identified two genes that were...